TITLE

USE OF 5-ASA IS ASSOCIATED WITH DECREASED RISK OF DYSPLASIA AND COLON CANCER IN ULCERATIVE COLITIS

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA119
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Risk factors for dysplasia and colon cancer (CRC) in ulcerative colitis (UC) include— duration and extent of disease, younger age of diagnosis, family history of CRC, and primary sclerosing cholangitis (PSC). Mesalazine (5-ASA) is a mainstay of UC treatment and has been suggested to have chemopreventive properties. This article cites a study conducted to determine the effect of 5-ASA use on risk for dysplasia and CRC in chronic UC. Results of the study suggest a chemopreventive role of 5-MA in the management of chronic UC.
ACCESSION #
13219279

 

Related Articles

  • The Cancer 'Fear' in IBD Patients: Is It Still REAL? Connelly, T.; Koltun, W. // Journal of Gastrointestinal Surgery;Jan2014, Vol. 18 Issue 1, p213 

    Increased rates of colorectal cancer (CRC) with high rates of progression from dysplasia to CRC are well documented in the inflammatory bowel disease (IBD) population. This increased risk in the presence of currently improving but still inadequate surveillance techniques confirms that the cancer...

  • Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease. Fiona D M van Schaik // Gut;Feb2012, Vol. 61 Issue 2, p235 

    BACKGROUND AND AIMS: Previous studies have suggested a chemopreventive effect of 5-aminosalicylic acid (5-ASA) therapy in patients with inflammatory bowel disease (IBD). This effect has not been reported in IBD patients using thiopurines. We investigated the association between thiopurine or...

  • The management of dysplasia associated with ulcerative colitis: colectomy versus continued surveillance. Friedlich, Martin S.; Guindi, Maha; Stern, Hartley S. // Canadian Journal of Surgery;Jun2004, Vol. 47 Issue 3, p212 

    The article focuses on the management of dysplasia associated with ulcerative colitis (UC). Colectomy versus continued surveillance in patients with longstanding UC is a challenging decision. Several factors must be considered. Often such patients have quiescent disease, making the prospect of...

  • Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis. van der Woude, C. J.; Moshage, H.; Homan, M.; Kleibeuker, J. H.; Jansen, P. L. M.; van Dekken, H. // Journal of Clinical Pathology;Aug2005, Vol. 58 Issue 8, p811 

    Background: Chronic ulcerative colitis (CUC) is associated with increased risk of developing colon cancer through a dysplasia (intraepithelial neoplasia)-carcinoma sequence. Aims: To investigate the expression of apoptosis and inflammatory related proteins in CUC. Methods: The expression of...

  • Cancer in inflammatory bowel disease. Jianlin Xie; Itzkowitz, Steven H. // World Journal of Gastroenterology;1/21/2008, Vol. 14 Issue 3, p378 

    Patients with long-standing inflammatory bowel disease (IBD) have an increased risk of developing colorectal cancer (CRC). Many of the molecular alterations responsible for sporadic colorectal cancer, namely chromosomal instability, microsatellite instability, and hypermethylation, also play a...

  • How to Manage the Risk of Colorectal Cancer in Ulcerative Colitis. Ali, Raja Affendi Raja; Egan, Laurence John // Current Drug Targets;Sep2011, Vol. 12 Issue 10, p1424 

    There is a strong association between chronic inflammation and cancer formation. This correlation has been well observed in patients with long standing inflammatory bowel disease (IBD) who are at high risk of colorectal cancer (CRC). At present, there is a lack of good markers for predicting the...

  • MANAGEMENT OF LOW AND HIGH GRADE DYSPLASIA IN INFLAMMATORY BOWEL DISEASE: A GASTROENTEROLOGIST'S PERSPECTIVE AND CURRENT PRACTICE IN UK.  // Gut;Apr2004 Supplement 3, Vol. 53, pA98 

    Colonic dysplasia is a precursor to cotorectal cancer (CRC) in inflammatory bowel disease (IBD). There is a risk of progression of low and high grade dysplasia (LGD and HGD) to CRC. A study has been conducted to get an overview of the gastroenteroloist's perspective on various aspects of colonic...

  • Darmkrebs-Screening macht Sinn. Sulz, Michael // Praxis (16618157);1/29/2014, Vol. 103 Issue 3, p123 

    No abstract available.

  • Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines. Hernández, Vicent; Clofent, Juan // Annals of Gastroenterology;Jul-Sep2012, Vol. 25 Issue 3, p193 

    Inflammatory bowel diseases (IBD) are associated to an increased risk of colorectal cancer, which is primarily related to long-standing chronic inflammation. Recognized risk factors are the duration and extent of the disease, severe endoscopic and histological inflammation, primary sclerosing...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics